Literature DB >> 24439028

Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Mark W Logue1, Matthew Schu2, Badri N Vardarajan2, John Farrell2, Kathryn L Lunetta3, Gyungah Jun4, Clinton T Baldwin2, Margaret M Deangelis5, Lindsay A Farrer6.   

Abstract

Several lines of inquiry point to overlapping molecular mechanisms between late-onset Alzheimer disease (AD) and age-related macular degeneration (AMD). We evaluated summarized results from large genome-wide association studies for AD and AMD to test the hypothesis that AD susceptibility loci are also associated with AMD. We observed association of both disorders with genes in a region of chromosome 7, including PILRA and ZCWPW1 (peak AMD SNP rs7792525, minor allele frequency [MAF] = 19%, odds ratio [OR] = 1.14, p = 2.34 × 10(-6)), and with ABCA7 (peak AMD SNP rs3752228, MAF = 0.054, OR = 1.22, p = 0.00012). Next, we evaluated association of AMD with genes in AD-related pathways identified by canonical pathway analysis of AD-associated genes. Significant associations were observed with multiple previously identified AMD risk loci and 2 novel genes: HGS (peak SNP rs8070488, MAF = 0.23, OR = 0.91, p = 7.52 × 10(-5)), which plays a role in the clathrin-mediated endocytosis signaling pathway, and TNF (peak SNP rs2071590, MAF = 0.34, OR = 0.89, p = 1.17 × 10(-5)), which is a member of the atherosclerosis signaling and the LXR/RXR activation pathways. Our results suggest that AMD and AD share genetic mechanisms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age related macular degeneration; Alzheimer disease; Gene-based test; Genetic association; Pathway analysis

Mesh:

Substances:

Year:  2013        PMID: 24439028      PMCID: PMC3961547          DOI: 10.1016/j.neurobiolaging.2013.12.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  83 in total

1.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

Authors:  Kaarin J Anstey; Chwee von Sanden; Agus Salim; Richard O'Kearney
Journal:  Am J Epidemiol       Date:  2007-06-14       Impact factor: 4.897

Review 2.  Clathrin-mediated endocytosis and Alzheimer's disease: an update.

Authors:  Fangbai Wu; Pamela J Yao
Journal:  Ageing Res Rev       Date:  2009-03-21       Impact factor: 10.895

3.  Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.

Authors:  Peter Lichtlen; Tim T Lam; T Michael Nork; Tim Streit; David M Urech
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

4.  Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells.

Authors:  Shripaad Y Shukla; Yogesh K Singh; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

5.  The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Karen J Cruickshanks
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

6.  Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation.

Authors:  Petroula Proitsi; Michelle K Lupton; Frank Dudbridge; Magda Tsolaki; Gillian Hamilton; Makrina Daniilidou; Megan Pritchard; Kathryn Lord; Belinda M Martin; Janet Johnson; David Craig; Stephen Todd; Bernadette McGuinness; Paul Hollingworth; Denise Harold; Iwona Kloszewska; Hilkka Soininen; Patrizia Mecocci; Bruno Velas; Michael Gill; Brian Lawlor; David C Rubinsztein; Carol Brayne; Peter A Passmore; Julie Williams; Simon Lovestone; John F Powell
Journal:  Neurobiol Aging       Date:  2012-02-01       Impact factor: 4.673

7.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

8.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

9.  Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.

Authors:  Yi Yu; Tushar R Bhangale; Jesen Fagerness; Stephan Ripke; Gudmar Thorleifsson; Perciliz L Tan; Eric H Souied; Andrea J Richardson; Joanna E Merriam; Gabriëlle H S Buitendijk; Robyn Reynolds; Soumya Raychaudhuri; Kimberly A Chin; Lucia Sobrin; Evangelos Evangelou; Phil H Lee; Aaron Y Lee; Nicolas Leveziel; Donald J Zack; Betsy Campochiaro; Peter Campochiaro; R Theodore Smith; Gaetano R Barile; Robyn H Guymer; Ruth Hogg; Usha Chakravarthy; Luba D Robman; Omar Gustafsson; Haraldur Sigurdsson; Ward Ortmann; Timothy W Behrens; Kari Stefansson; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Caroline C W Klaver; Rando Allikmets; Milam A Brantley; Paul N Baird; Nicholas Katsanis; Unnur Thorsteinsdottir; John P A Ioannidis; Mark J Daly; Robert R Graham; Johanna M Seddon
Journal:  Hum Mol Genet       Date:  2011-06-10       Impact factor: 6.150

10.  From genomics to chemical genomics: new developments in KEGG.

Authors:  Minoru Kanehisa; Susumu Goto; Masahiro Hattori; Kiyoko F Aoki-Kinoshita; Masumi Itoh; Shuichi Kawashima; Toshiaki Katayama; Michihiro Araki; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  22 in total

Review 1.  Differential Gene Expression in Age-Related Macular Degeneration.

Authors:  Denise J Morgan; Margaret M DeAngelis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

2.  Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strains.

Authors:  Elena E Korbolina; Anna A Zhdankina; Anzhela Zh Fursova; Oyuna S Kozhevnikova; Natalia G Kolosova
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

3.  Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.

Authors:  Elena E Korbolina; Nikita I Ershov; Leonid O Bryzgalov; Natalia G Kolosova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

4.  Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.

Authors:  Jasmeet P Hayes; Mark W Logue; Naomi Sadeh; Jeffrey M Spielberg; Mieke Verfaellie; Scott M Hayes; Andrew Reagan; David H Salat; Erika J Wolf; Regina E McGlinchey; William P Milberg; Annjanette Stone; Steven A Schichman; Mark W Miller
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 5.  The value of nutritional supplements in treating Age-Related Macular Degeneration: a review of the literature.

Authors:  Sabrina Mukhtar; Balamurali K Ambati
Journal:  Int Ophthalmol       Date:  2019-07-16       Impact factor: 2.031

6.  Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorder.

Authors:  Monica Uddin; Andrew Ratanatharathorn; Don Armstrong; Pei-Fen Kuan; Allison E Aiello; Evelyn J Bromet; Sandro Galea; Karestan C Koenen; Benjamin Luft; Kerry J Ressler; Derek E Wildman; Caroline M Nievergelt; Alicia Smith
Journal:  Epigenomics       Date:  2018-11-20       Impact factor: 4.778

Review 7.  Genetics of age-related macular degeneration (AMD).

Authors:  Margaret M DeAngelis; Leah A Owen; Margaux A Morrison; Denise J Morgan; Mingyao Li; Akbar Shakoor; Albert Vitale; Sudha Iyengar; Dwight Stambolian; Ivana K Kim; Lindsay A Farrer
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

Review 8.  Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD).

Authors:  Yuhai Zhao; Surjyadipta Bhattacharjee; Brandon M Jones; James M Hill; Christian Clement; Kumar Sambamurti; Prerna Dua; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.590

9.  Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degeneration.

Authors:  Lindsay A Farrer; Margaret M DeAngelis
Journal:  Stem Cell Investig       Date:  2017-11-17

10.  Transethnic genome-wide scan identifies novel Alzheimer's disease loci.

Authors:  Gyungah R Jun; Jaeyoon Chung; Jesse Mez; Robert Barber; Gary W Beecham; David A Bennett; Joseph D Buxbaum; Goldie S Byrd; Minerva M Carrasquillo; Paul K Crane; Carlos Cruchaga; Philip De Jager; Nilufer Ertekin-Taner; Denis Evans; M Danielle Fallin; Tatiana M Foroud; Robert P Friedland; Alison M Goate; Neill R Graff-Radford; Hugh Hendrie; Kathleen S Hall; Kara L Hamilton-Nelson; Rivka Inzelberg; M Ilyas Kamboh; John S K Kauwe; Walter A Kukull; Brian W Kunkle; Ryozo Kuwano; Eric B Larson; Mark W Logue; Jennifer J Manly; Eden R Martin; Thomas J Montine; Shubhabrata Mukherjee; Adam Naj; Eric M Reiman; Christiane Reitz; Richard Sherva; Peter H St George-Hyslop; Timothy Thornton; Steven G Younkin; Badri N Vardarajan; Li-San Wang; Jens R Wendlund; Ashley R Winslow; Jonathan Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard Schellenberg; Kathryn L Lunetta; Lindsay A Farrer
Journal:  Alzheimers Dement       Date:  2017-02-07       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.